Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3Plasma cell 2Lymphoid 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Multiple Myeloma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Primary Myelofibrosis 4Leukemia, Myelomonocytic, Chronic 4Leukemia 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Polycythemia Vera 2Myeloproliferative Disorders 2Lymphoma 2Hematologic Neoplasms 2Hematologic Diseases 2Thrombocytopenia 1Thrombocythemia, Essential 1Severe Combined Immunodeficiency 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1

Interventions

Cyclophosphamide 4fludarabine phosphate 2fludarabine 2Stem Cell Transplantation 2Platelet Transfusion 2Mycophenolic Acid 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bone Marrow Transplantation 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1cedazuridine 1Thiotepa 1Tacrolimus 1Sertraline 1Rituximab 1Observation 1Methotrexate 1Cyclosporine 1Cholecalciferol 1Brentuximab Vedotin 1Biopsy 1Azacitidine 1Aspirin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × Stem Cell Transplantation × Classical hematology × Clear all
NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00000603 2016-04-14

Cord Blood Stem Cell Transplantation Study (COBLT)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 2 Completed
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Fanconi Anemia, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Neoplasms, Severe Combined Immunodeficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡